Ritalin vs Adderall vs Vyvanse (and Concerta, Dexedrine): How They Differ

The labels list heart attack, stroke, seizures, and dangerous overheating among the effects of a stimulant overdose. Naloxone does not reverse a stimulant.

Ritalin vs Adderall vs Vyvanse: what is the difference?

Two molecules, many containers. Ritalin and Concerta are methylphenidate. Adderall, Vyvanse, and Dexedrine are amphetamines. Within each family, the brands differ mainly in how fast the drug is released and how long it lasts.

They are not interchangeable, and they are not ranked. All five are Schedule II controlled substances, the DEA’s category for drugs with a high potential for abuse that can lead to severe psychological or physical dependence. Which one works better is a question about a specific person, not about the drugs.

Ritalin, Concerta, Adderall, Vyvanse, and Dexedrine side by side

Every row comes from the FDA labels on DailyMed. Peak times and half-lives are label figures from study volunteers; they are not doses and not a guide to switching.

Amphetamine vs methylphenidate

They are different molecules with a similar job. The Ritalin label says methylphenidate blocks the reuptake of norepinephrine and dopamine and increases their release. The Adderall label describes amphetamine in almost the same words. You will read online that one only blocks reuptake and the other only releases. The labels do not draw that line.

The difference the labels do show is time. In adults, methylphenidate’s half-life is about 3.5 hours; amphetamine’s is about 10 to 13.

Adderall vs Vyvanse

Adderall is amphetamine you swallow ready to work. Vyvanse is amphetamine with a lysine molecule attached. The Vyvanse label calls it a prodrug: the body converts it into dextroamphetamine and lysine, mainly in the blood, through the activity of red blood cells.

In practice that means a long day. In the label’s adult study, attention scores beat placebo at every time point measured, from 2 to 14 hours after the dose. Adderall XR gets its length a different way: the capsule holds two kinds of beads, one immediate-release and one delayed-release.

Is Vyvanse harder to misuse than Adderall?

The label makes no such claim. In an abuse-liability study in the Vyvanse label, people with a history of drug abuse liked it less than immediate-release dextroamphetamine at one dose and about as much at a higher one. Being a prodrug does not remove the high, and the Vyvanse label carries the same boxed warning as Adderall’s.

Dexedrine vs Vyvanse

Vyvanse becomes dextroamphetamine in the body; Dexedrine is dextroamphetamine to begin with. The Spansule capsule releases part of its dose right away and the rest over a longer period, peaking around 8 hours, with a half-life of about 12 hours. Dexedrine is also approved for narcolepsy, which Vyvanse is not.

Concerta vs Ritalin

Both are methylphenidate. Ritalin is the immediate-release form, usually taken two or three times a day and peaking in about 2 hours. Concerta is a once-daily extended-release tablet whose levels peak at 6 to 10 hours, and in its trials the benefit held through 12 hours after dosing.

The label says to swallow Concerta whole and never split, crush, or chew it, because that breaks the extended release and may compromise safety. If a tablet will not go down, that is a question for the prescriber, not a kitchen knife.

Vyvanse to Adderall conversion: why there is no chart here

People search for a Vyvanse-to-Adderall conversion, often because a pharmacy is out of one. None of these labels gives a milligram equivalence between Vyvanse and Adderall, or between an amphetamine and methylphenidate. The conversion charts online are not FDA label content.

The labels do address switching within a single drug. The Adderall XR label covers moving from immediate-release Adderall to Adderall XR, and the Concerta label has a table for moving from immediate-release methylphenidate to Concerta. Both are starting points that the prescriber sets and then adjusts. Neither covers a jump from one drug family to another.

So a switch from Vyvanse to Adderall, or from an amphetamine to methylphenidate, is a new prescription, set and adjusted by the prescriber. If the reason is a shortage, call the prescriber before the last pill.

Are ADHD medications still in shortage?

Some are. As of October 2, 2026, the FDA drug shortage database still listed mixed amphetamine salts tablets (first posted October 12, 2022), lisdexamfetamine capsules and chewable tablets (first posted July 14, 2023), and extended-release methylphenidate tablets (first posted July 26, 2023) as current shortages. A listing does not mean every strength is gone: FDA’s entries show some strengths from some makers as available, so ask the pharmacy. A gap in supply is also the point where some people start buying pills from friends or online.

Is Adderall more addictive than Ritalin or Vyvanse?

The FDA treats them as one risk. In a May 11, 2023 safety communication, it required the boxed warning to describe misuse, abuse, addiction, and overdose the same way across every prescription stimulant.

The FDA found that most people who misuse a prescription stimulant get it from friends or family, between 56 and 80 percent across the estimates it reviewed. The labels now tell patients not to give the medicine to anyone else, and the FDA warns that sharing can lead to addiction in the person who receives it. Keep the bottle locked up.

Snorting or smoking Adderall, Ritalin, or Vyvanse

Each of the five labels names snorting and injection as “unapproved methods of administration” that raise the risk of overdose and death. Smoking is not an approved route either. The only approved route for any of these is by mouth, as prescribed. Changing the route is misuse whatever the reason, and the FDA’s review of poison center cases from 2001 to 2018 found that about 70 percent of cases that mentioned injection involved moderate or major medical effects.

College students and “study drugs”

In the studies the FDA reviewed (published 2006 to 2020), past-year nonmedical use was higher among young adults ages 18 to 25 (4.1 to 7.5 percent across estimates) and college students (4.3 percent, a nationally representative estimate). The FDA found the usual reason is to do better at school or work. For grades, the evidence does not support it. A study of 898 undergraduates without ADHD, using GPAs from college records, found that students who used stimulants nonmedically showed no rise in GPA and no detectable advantage over peers who did not, while the nonusers’ GPAs went up. The authors could not rule out that the pills prevented a drop, but called the promised academic benefit likely illusory. In a separate survey, 28.6 percent of college students agreed that the pills could help students earn higher grades, and 38 percent were unsure.

Counterfeit Adderall: meth and fentanyl in a familiar pill

A pill that looks like Adderall is not proof that it is Adderall. The DEA’s fake pill fact sheet says many counterfeits are made to look like stimulants such as Adderall but contain fentanyl or methamphetamine. Its list of counterfeited drugs includes Adderall, Concerta, Dexedrine, and Ritalin. Counterfeiters copy colors and imprints, so the blue Adderall imprint guide and the E 344 guide identify pharmacy tablets, not street ones.

The DEA’s rule is the only reliable one: the safe medications are the ones prescribed by a trusted medical professional and dispensed by a licensed pharmacist. Someone who buys a “study pill” expecting to stay awake may be swallowing an opioid they have never taken before, or methamphetamine, a different drug entirely. Our page on whether Adderall is meth covers how close the two molecules are and where they differ.

Phentermine: an amphetamine cousin, a different schedule

Phentermine is a weight-loss stimulant, not an ADHD drug. Its label says it is related chemically and pharmacologically to the amphetamines, and it is Schedule IV, the DEA category for drugs with a low potential for abuse and low risk of dependence.

How long does phentermine stay in your system?

The phentermine and topiramate label puts phentermine’s average half-life at about 20 hours, and 70 to 80 percent of a dose leaves in the urine unchanged. That is an average, not a countdown for any one person. Detection on a drug test depends on the test, which these labels do not address.

When misuse becomes a stimulant use disorder

Misuse, in NIDA’s terms, means taking a medication in a way or dose other than prescribed, taking someone else’s prescription, or taking it to feel euphoria. Patterns that should prompt a real conversation:

• Taking more than prescribed, or running out before the refill date
• Getting pills from friends, family, or online sellers
• Snorting, smoking, or injecting instead of swallowing
• Needing more for the same effect, which the labels call tolerance. The labels also say physical dependence can develop even when the drug is taken as directed, so this sign matters most alongside the others
• Crashing into exhaustion and low mood when the pills run out
• Moving on to methamphetamine or cocaine when pills are scarce

Someone who was prescribed the drug and has started taking extra should tell the prescriber, and talk with them before stopping or cutting down, since the labels list withdrawal symptoms after an abrupt stop or a dose reduction following prolonged use.

What stimulant withdrawal looks like

Every one of these labels lists the same withdrawal picture after abrupt discontinuation or a dose reduction following prolonged use: low or irritable mood, depression, fatigue, vivid unpleasant dreams, sleeping too little or too much, increased appetite, and slowed or restless movement. Our Adderall withdrawal guide covers the crash, the timeline and the mood risk in detail.

The timeline comes from a 2005 study of 21 inpatients in Thailand withdrawing from methamphetamine. It did not study prescription amphetamine or methylphenidate, so treat the days as a rough shape, not a schedule. A 2009 Cochrane review found no medication effective for amphetamine withdrawal, and the 2024 ASAM/AAAP guideline says the medication studies since are mostly small and of low quality.

Watch the mood during withdrawal. The ASAM/AAAP guideline warns that suicidal thinking can rise as the drug wears off and withdrawal begins, and that depression, anxiety, poor sleep, and paranoia can last weeks to months. If someone is in immediate danger, call 911. For thoughts of suicide, call or text 988. Our stimulant detox guide covers the crash, the weeks after, and when a supervised setting is the right call.

Detox and treatment for prescription stimulants

NIDA says the first step for some people is tapering the dose to ease withdrawal, with behavioral treatment to follow. There is no FDA-approved medication for stimulant addiction. The 2024 ASAM/AAAP guideline calls contingency management, a structured program that gives tangible rewards for negative drug tests, the current standard of care for stimulant use disorder. Ask any program you call whether it offers it.

The 2024 ASAM/AAAP guideline says high fever, seizure, chest pain, psychosis, and suicidal thinking usually need emergency care, which means 911. Otherwise it matches the setting to the person: closer monitoring makes sense with serious medical or psychiatric conditions, or when opioids, alcohol, or sedatives are involved too, which pills bought on the street can hide. Tell the intake team every substance involved, including alcohol and anything bought as a pill. Same-day admission is sometimes possible, not guaranteed. Our list of what to bring to detox covers the rest, and signs you need detox helps if you are not sure.

In New Jersey

For addiction treatment, New Jersey has a specific rule. Fully insured New Jersey plans and the State Health Benefits and School Employees’ plans cannot require prior authorization for the first 180 days per plan year of in-network treatment your own physician, psychologist or psychiatrist finds medically necessary. Self-funded employer plans, Medicare and Medicaid are not covered by that rule. Our insurance guides go plan by plan. ReachNJ, the state treatment line, is at 1-844-732-2465.

Periscope Behavioral Health, which publishes this site, is opening a medical detox in Hammonton, Atlantic County, expected Summer 2027. For help independent of us, the state’s IME Addictions Access Center at 1-844-276-2777 screens NJ FamilyCare and uninsured residents and refers them to treatment. Until the Hammonton detox opens, the admissions line of our publisher, Periscope Behavioral Health, at (888) 313-3583, can talk through options in New Jersey and Florida, including facilities Periscope operates. What a plan covers depends on the plan and the facility’s network status.